Update on blood‐based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience
Abstract Liver cirrhosis is the final stage of chronic liver disease (CLD) and is associated with high morbidity and mortality. Various complications such as portal hypertension, ascites retention, hepatic encephalopathy, and hepatorenal syndrome deeply affect patient outcome. The most common tools...
Guardado en:
Autores principales: | Motoh Iwasa, Ryuta Shigefuku, Akiko Eguchi, Yasuyuki Tamai, Yoshiyuki Takei |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/11754e7c2d96405fa5479faf69d9ced1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Copeptin as a novel marker predicting prognosis of liver cirrhosis and its major complications
por: Tawfik AK, et al.
Publicado: (2018) -
Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure
por: Annarein J.C. Kerbert, et al.
Publicado: (2021) -
Step by Step: Managing the Complications of Cirrhosis
por: Perez IC, et al.
Publicado: (2021) -
Perioperative Evolution of Sodium Levels in Cirrhotic Patients Undergoing Liver Transplantation: An Observational Cohort and Literature Review
por: Zamberg I, et al.
Publicado: (2021) -
Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study
por: Tracey G. Simon, et al.
Publicado: (2021)